NO20043818L - Fast formulering med kontrollert frigjoring som et nytt medikament-leveringssystem med redusert risiko for overdose - Google Patents

Fast formulering med kontrollert frigjoring som et nytt medikament-leveringssystem med redusert risiko for overdose

Info

Publication number
NO20043818L
NO20043818L NO20043818A NO20043818A NO20043818L NO 20043818 L NO20043818 L NO 20043818L NO 20043818 A NO20043818 A NO 20043818A NO 20043818 A NO20043818 A NO 20043818A NO 20043818 L NO20043818 L NO 20043818L
Authority
NO
Norway
Prior art keywords
overdose
delivery system
drug delivery
controlled release
release formulation
Prior art date
Application number
NO20043818A
Other languages
English (en)
Norwegian (no)
Inventor
M Zahirul I Khan
Aleksandra Krajacic
Zdravka Knezevic
Snjezana Vodopija-Mandic
Original Assignee
Pliva Istraz Ivanje I Razvoj D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istraz Ivanje I Razvoj D filed Critical Pliva Istraz Ivanje I Razvoj D
Publication of NO20043818L publication Critical patent/NO20043818L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20043818A 2002-02-11 2004-09-10 Fast formulering med kontrollert frigjoring som et nytt medikament-leveringssystem med redusert risiko for overdose NO20043818L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20020124A HRP20020124A2 (en) 2002-02-11 2002-02-11 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
PCT/HR2002/000018 WO2003074033A1 (en) 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Publications (1)

Publication Number Publication Date
NO20043818L true NO20043818L (no) 2004-09-30

Family

ID=27772919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043818A NO20043818L (no) 2002-02-11 2004-09-10 Fast formulering med kontrollert frigjoring som et nytt medikament-leveringssystem med redusert risiko for overdose

Country Status (17)

Country Link
US (1) US20050118266A1 (et)
EP (1) EP1474112A1 (et)
JP (1) JP2006507216A (et)
AU (1) AU2004205184A1 (et)
BG (1) BG108870A (et)
CA (1) CA2476050A1 (et)
CZ (1) CZ2004931A3 (et)
EE (1) EE200400110A (et)
HR (1) HRP20020124A2 (et)
HU (1) HUP0500097A3 (et)
IS (1) IS7386A (et)
NO (1) NO20043818L (et)
PL (1) PL371787A1 (et)
RS (1) RS70704A (et)
RU (1) RU2004127237A (et)
SK (1) SK3302004A3 (et)
WO (1) WO2003074033A1 (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244324B1 (es) 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
WO2009042721A1 (en) * 2007-09-25 2009-04-02 Neosync, Inc. Systems and methods for neuro-eeg synchronization therapy
US8926490B2 (en) * 2008-09-24 2015-01-06 Neosync, Inc. Systems and methods for depression treatment using neuro-EEG synchronization therapy
WO2011017466A1 (en) 2009-08-06 2011-02-10 Neosync, Inc. Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy
EP2480212B1 (en) * 2009-09-25 2016-07-06 Novartis Consumer Health S.A. Oral pharmaceutical composition comprising diclofenac
WO2011059986A1 (en) * 2009-11-12 2011-05-19 Neosync, Inc. Systems and methods for neuro-eeg synchronization therapy
JP5714562B2 (ja) 2010-02-22 2015-05-07 第一三共株式会社 経口用徐放性固形製剤
ES2706880T3 (es) 2010-02-22 2019-04-01 Daiichi Sankyo Co Ltd Preparación sólida de liberación sostenida para uso oral
EP2544667B1 (en) * 2010-03-09 2018-11-14 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
ES2706994T3 (es) 2012-09-03 2019-04-02 Daiichi Sankyo Co Ltd Composición farmacéutica de liberación prolongada de administración oral que contiene clorhidrato de hidromorfona
WO2014060857A1 (en) * 2012-10-19 2014-04-24 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
US10588576B2 (en) 2014-08-15 2020-03-17 Neosync, Inc. Methods and device for determining a valid intrinsic frequency
JP1602547S (et) 2017-01-17 2018-04-23

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156886B (et) * 1981-08-22 1985-11-30 Council Scient Ind Res
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
US4948581A (en) * 1989-02-17 1990-08-14 Dojin Iyaku-Kako Co., Ltd. Long acting diclofenac sodium preparation
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
CA2146999A1 (en) * 1992-10-16 1994-04-28 Stephen John Douglas Taste-masking compositions of ranitidine
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
CN1165291C (zh) * 1996-05-20 2004-09-08 詹森药业有限公司 具有改进的生物利用度的抗真菌组合物
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin

Also Published As

Publication number Publication date
PL371787A1 (en) 2005-06-27
CZ2004931A3 (cs) 2005-03-16
CA2476050A1 (en) 2003-09-12
EE200400110A (et) 2004-10-15
US20050118266A1 (en) 2005-06-02
WO2003074033A1 (en) 2003-09-12
JP2006507216A (ja) 2006-03-02
BG108870A (en) 2005-12-30
SK3302004A3 (sk) 2005-04-01
RS70704A (en) 2006-10-27
RU2004127237A (ru) 2005-04-20
EP1474112A1 (en) 2004-11-10
HRP20020124A2 (en) 2003-10-31
IS7386A (is) 2004-08-05
HUP0500097A2 (hu) 2005-07-28
AU2004205184A1 (en) 2005-03-03
WO2003074033A8 (en) 2004-07-08
HUP0500097A3 (en) 2008-04-28

Similar Documents

Publication Publication Date Title
NO20043818L (no) Fast formulering med kontrollert frigjoring som et nytt medikament-leveringssystem med redusert risiko for overdose
NO20054555D0 (no) Farmasoytiske preparater som omfatter syrestabilisert insulin
AU2003221770A1 (en) Controlled release transdermal drug delivery
DK1530965T3 (da) Kontrolleret frigivelsesleveringssystem til nasal applikation
IL166431A0 (en) Microcapsules with modified release of active principles with low solubility for oral delivery
AU2003295614A1 (en) Delivery of pharmaceutical agents via the human insulin receptor
AU2003287640A1 (en) Inertial drug delivery system
AU2003276656A8 (en) Transdermal delivery system for anti-emetic medication
EP1490029A4 (en) DRUG DELIVERY SYSTEM WITH CONTROLLED RELEASE OF PRAVASTATIN
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
HK1072194A1 (en) Oral dosage form for controlled drug release
AU2003212962A8 (en) Transdermal drug delivery systems
AU2003231260A1 (en) Catechin multimers as therapeutic drug delivery agents
DE60321572D1 (de) Transdermales arzneimittelverabreichungssystem
ITMI20041255A1 (it) Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive
NO20043243L (no) Legemiddelleveringssystem for vedvarende frigivelse av glipizid
AU2003275006A8 (en) Aerosol drug delivery system employing formulation pre-heating
ITMI20020921A0 (it) Dispositivo per la sommistrazione di farmaci
GB2405094B (en) Pharmaceutical composition for controlled drug delivery system
GB0201607D0 (en) Formulation for the administration of medicinal substances
AU2003230034A1 (en) Transdermal delivery device for the administration of fentanyl
AU2003254672A8 (en) Dual-spike release formulation for oral drug delivery
ZA200204331B (en) Pharmaceutical composition for controlled drug delivery system.
GB0229836D0 (en) Transdermal delivery device for the administration of fentanyl
ES1053036Y (es) Dispositivo para suministro de medicacion intravenosa.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application